Epidemiology and clinical course of bronchiolitis in hospitalized children in tertiary care hospital in Kashmir

Mohammad Imran Malik; Khurshid Ahmad Wani; Ruhail Ahmad Baba; Irshad Ahmad Kumar

doi:10.18203/2349-3291.ijcp20230725

Authors

Mohammad Imran Malik Department of Pediatrics, GMC Srinagar, Jammu and Kashmir, India
Khurshid Ahmad Wani Department of Pediatrics, GMC Srinagar, Jammu and Kashmir, India
Ruhail Ahmad Baba Department of Pediatrics, GMC Srinagar, Jammu and Kashmir, India
Irshad Ahmad Kumar Directorate Health Services Kashmir, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230725

Keywords:

Bronchiolitis, Winter, RSV

Abstract

Background: Bronchiolitis is the commonest lower respiratory tract infection in children < 2 years of age and is responsible for the majority of their pediatrician visits and hospital admission during the winter season. The aim of this study was to describe the epidemiological data, seasonal trends, clinical characteristics, and outcomes of children admitted with bronchiolitis in pediatric hospital GMC Srinagar.

Methods: This was a retrospective observational study in children less than 2 years of age admitted in department of pediatrics in GMC Srinagar. Data were collected through review of the medical records of patients with a diagnosis of bronchiolitis on discharge and analyzed through SPSS 20.

Results: A total of 228 infants were enrolled in the study. The majority were males (60.08%). The median age on admission was 5.5 months, exclusive breastfeeding was the mode of feeding in majority and 8.77% were ex-preterm. Respiratory syncytial virus (RSV) was identified in majority (103) and admission peak was from October to March. Most of the patients presented on day 3 of the illness. Most patients 45.17% were having feeding difficulties and chest auscultation was normal in about 22% of the children. Oxygen supplementation was administered to 85.52% of the children. The 32 children (14.03%) required admission to PICU. Mechanical ventilation was required in 6 children (18.75%). No death occurred in infants while in the hospital.

Conclusions: RSV has been found to be the main responsible virus. Management of bronchiolitis is usually symptomatic as recommended by most of the guidelines.

Metrics

Metrics Loading ...

References

Miller EK, Gebretsadik T, Carroll KN, Dupont WD, Mohamed YA, Morin LL et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J. 2013;32(9):950-55.

Wainwright C. Acute viral bronchiolitis in children-A very common condition with few therapeutic options. Paediatr Respir Rev. 2010;11(1):39-45.

Nelson Text-Book of Pediatrics Twenty First Edition.

Aygün D, Erbek F, Kuşkucu M, Şener D, Köşker M, Varol F et al. The epidemiologic and clinical features of viral agents among hospitalized children with lower respiratory tract infections. Turk. Pediatri Ars. 2020;55(2):166-73.

Al-Ayed MS, Asaad AM, Qureshi MA, Ameen MS. Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction. Saudi Med. J. 2014;35(11):1348-53.

Hasegawa K, Pate BM, Mansbach JM, Macias CG, Fisher ES, Piedra PA et al. Risk factors for requiring intensive care among children admitted toward with bronchiolitis. Acad Pediatr. 2015;15(1):77-81.

Health NSW. In: PD2012_004 Infants and Children: Acute Management of Bronchiolitis. 2nd ed. Health N.M.O., editor. North Ryde: NSW Ministry of Health. 2012.

Skjerven HO, Megremis S, Papadopoulos NG, Mowinckel P, Carlsen KH, Lødrup Carlsen K. ORAACLE Study Group Virus type and genomic load in acute bronchiolitis: severity and treatment response with inhaled adrenaline. J Infect Dis. 2016;213(6):915-21.

Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, Anderson LJ. The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol. 2003;77(11):6580-4.

Tsolia MN, Kafetzis D, Danelatou K, Astral H, Kallergi K, Spyridis P, Karpathios TE. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol. 2003;18(1):55-61.

Mlinarić-Galinović G, Ugrcić I, Bozikov J. Respiratory syncytial virus infections in SR Croatia, Yugoslavia. Pediatr Pulmonol. 1987;3(5):304-8.

Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003;22(2):S13-8.

Kramer R, Duclos A. Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France. Vaccine. 2018;S0264-410X(18):31289-1.

Richter J, Nikolaou E, Panayiotou C, Tryfonos C, Koliou M, Christodoulou C. Molecular epidemiology of rhinoviruses in Cyprus over three consecutive seasons. Epidemiol Infect. 2015;143(9):1876-83.

Green CA, Yeates D, Goldacre A, Sande C, Parslow RC, McShane P et al. Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma. Arch Dis Child. 2016;101(2):140-6.

Singleton RJ, Bruden D, Bulkow LR. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Pediatr Infect Dis J. 2007;26(11):S46-50.

Law BJ, Langley JM, Allen U, Paes B, Lee DSC, Mitchell I et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23(9):806-14.

Hasegawa K, Jartti T, Mansbach JM, Laham FR, Jewell AM, Espinola JA et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis. 2015;211(10):1550-9.

Rivera-Sepulveda A, Garcia-Rivera EJ. Epidemiology of bronchiolitis: A description of emergency department visits and hospitalizations in Puerto Rico, 2010-2014. Trop Med Health. 2017;45:24.

Yorita KL, Holman RC, Steiner CA, Effler PV, Miyamura J, Forbes S et al. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii. Pediatr Infect Dis J. 2007;26(12):1081-8.

Werno AM, Anderson TP, Jennings LC, Jackson PM, Murdoch DR. Human metapneumovirus in children with bronchiolitis or pneumonia in New Zealand. J Paediatr Child Health. 2004;40(9-10):549-51.

Haynes AK, Manangan AP, Iwane MK, Sturm-Ramirez K, Homaira N, Brooks WA et al. Respiratory syncytial virus circulation in seven countries with global disease detection regional centers. J Infect Dis. 2013;208(3):S246-54.

Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845-63.

Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Bont L, Checchia PA et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among preterm infants without chronic lung disease or congenital heart disease. Infect Dis Ther. 2016;5(4):417-52.

Koul PA, Saha S, Kaul KA, Mir H, Potdar V, Chadha M et al. Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India. J Glob Health. 2022;12:04050.

Silver AH, Nazif JM. Bronchiolitis. Pediatr Rev. 2019;40(11):568-76.

Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389(10065):211-24.

Schützle H, Weigl J, Puppe W, Forster J, Berner R. Diagnostic performance of a rapid antigen test for RSV in comparison with a 19-valent multiplex RT-PCR ELISA in children with acute respiratory tract infections. Eur J Pediatr. 2008;167(7):745-9.

Rodríguez DA, Rodríguez-Martínez CE, Cárdenas AC, Quilaguy IE, Mayorga LY et al. Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region. Pediatr Pulmonol. 2014;49(3):269-76.

Farley R, Spurling GK, Eriksson L, Del Mar C.B. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014;(10):CD005189.

Skjerven HO, Rolfsjord LB, Berents TL, Engen H, Dizdarevic E, Midgaard C et al. Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: follow-up from the randomized, controlled, double-blind, Bronchiolitis ALL trial. Lancet Respir Med. 2015;3(9):702-8.

Cahill AA, Cohen J. Improving evidence-based bronchiolitis care. Clin Pediatr Emerg Med. 2018;19(1):33-9.